Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906368 · ClinicalTrials.gov registry record · NA
Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypotension
A NA study, sponsored by Grace Lim, MD, MS.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05906368 is a NA study that has completed, run by Grace Lim, MD, MS. The registered enrollment target is 34 participants.
The verdict
NCT05906368, a NA study, has completed, sponsored by Grace Lim, MD, MS.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this pilot trial is to examine the feasibility and ease of use of monitoring by ClearSight in laboring and delivering patients with the intent to compare time-to-treatment of hypotension between conventionally monitored patients (Group CM) and those receiving HPI (Group CM + HPI) monitoring by ClearSight, in a population of healthy laboring women who receive epidural analgesia.
Interventions
- DIAGNOSTIC_TEST ClearSight HPI Monitoring system
- DIAGNOSTIC_TEST Standard of Care Blood Pressure Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2024-04-18 |
| Est. Completion | 2024-08-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05906368
The ClinicalTrials.gov registry entry for NCT05906368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Grace Lim, MD, MS, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ClearSight HPI Monitoring system is the first listed.
NCT05906368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05906368 about?
NCT05906368 is a clinical study titled "Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypotension". The purpose of this pilot trial is to examine the feasibility and ease of use of monitoring by ClearSight in laboring and delivering patients with the intent to compare time-to-treatment of hypotension between conventionally monitored patients (Group CM) and those receiving HPI (Group CM + HPI) moni...
What is the current status of trial NCT05906368?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2024-04-18. Estimated completion is 2024-08-29.
What interventions are being tested in trial NCT05906368?
The interventions under investigation include: ClearSight HPI Monitoring system (DIAGNOSTIC_TEST), Standard of Care Blood Pressure Monitoring (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05906368?
This trial is sponsored by Grace Lim, MD, MS, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.